tirzepatide surpass 2 Efficacy and safety of in children and adolescents with type diabetes (SURPASS-PEDS): a randomised, double-blind, placebo-controlled, phase 3 trial Read now: The SURPASS-EARLY trial
Pay in 4 interest-free payments of $5.05 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28




























